PBS SF (μ) PBS /(μ) SF Experiment 1 μ 0 0.023±0.008 0.017±0.004* 1.5 μ min 0.021±0.009 0.014±0.008* 1.3 μ f 0.022±0.009 0.015±0.003* 1.5 Experiment 2 μ min 0.0027±0.0011 0.0015±0.0003* † 1.8 μ eq 0.155±0.017 0.088±0.008* † 1.8 μ eq /μ min 57 59 *p<0.05, SF vs PBS. † p<0.05, μeq vs μmin. 
Conclusions:
The transient frictional response observed in Experiment 2 (Fig. 1 ) has been shown to correlate with the magnitude of interstitial fluid pressurization in our previous studies. μ min is achieved immediately upon loading, when the pressure is greatest; μ eq is achieved after a prolonged duration, when the pressure has subsided. Therefore, the ratio μ eq /μ min represents the effectiveness of interstitial fluid pressurization in reducing friction. Conversely, the effectiveness of synovial fluid as a boundary lubricant can be assessed from the ratio (μ PBS )/(μ SF ), equally applicable for μ 0 , μ min , μ f and μ eq . As seen in the last column and last row of Table 1 , SF reduces the friction coefficient by a factor of 2 at most, whereas interstitial fluid pressurization reduces it by a factor of nearly 60. Therefore, cartilage interstitial fluid pressurization is far more effective at reducing friction than boundary lubrication by synovial fluid. While the configuration of Experiment 2 is ideal for assessing the effectiveness of interstitial fluid pressurization, it is not representative of physiological loading conditions since it produces an elevated, potentially detrimental friction coefficient under equilibrium conditions, when the fluid pressure has subsided. In contrast, Experiment 1 shows that under physiological loading conditions, where natural cartilage surfaces slide against each other with migrating contact areas, there is no loss of interstitial fluid pressurization and the friction coefficient remains low for prolonged loading durations. Either experiment is able to demonstrate the effectiveness of SF as a boundary lubricant, by comparing SF to PBS; however, only Experiment 2 can demonstrate the effectiveness of interstitial fluid pressurization.
IMAGING OF CARTILAGE -CHANGE IN PARADIGMS

Thomas Link
In the last decade therapeutic management of cartilage injury and degeneration has changed substantially. Currently cartilage repair techniques and pharmacological therapies are areas of major clinical interest and research, in particular to prevent and treat osteoarthritis. Given these advancements adequate diagnostic techniques are required to better assess outcome of new therapies and to tailor therapies for individual patients.
Radiographs are limited and MRI clearly has been shown to provide superior information concerning cartilage, the underlying bone and internal structures of the joints, including ligaments and menisci. Traditionally morphologic, pathological cartilage changes in MR images have been described and defects have been classified semi quantitatively, as lesions with more or less than 50% loss or full thickness lesions. Visualization of these cartilage lesions has been substantially improved (i) with dedicated cartilages sequences, such as proton density-weighted fast spin echo, spoiled gradient echo and dual echo steady state sequences, and (ii) with the event of clinical 3.0T high field MRI. New sequences are also currently studied to optimize cartilage imaging, which include driven equilibrium Fourier transform and steady-state free precession based imaging.
Since these techniques may be of limited value to study early disease and may have limitations in the assessment of disease progression quantitative techniques have been established to determine cartilage volume. These techniques may be particularly useful to study the significance of new pharmacological cartilage protective therapies. New developments now aim at quantifying pathological changes of the cartilage matrix before damage of the tissue is morphologically evident. Since cartilage loss is irreversible these new techniques would allow to diagnose and potentially treat early degeneration at a stage when the cartilage surface is still intact and changes may be reversible. The most widely applied techniques to study cartilage matrix are currently (i) dGEMRIC (delayed gadolinium enhanced magnetic resonance imaging of cartilage), (ii) T2 relaxation time measurements and (iii) T1rho mapping techniques. These techniques have shown merit in determining the amount of macromolecules, such as glycosaminoglycans, within the cartilage and quantifying its water content. In summary MRI's role in cartilage imaging is evolving with new diagnostic requirements; while assessment of cartilage morphology is still standard, innovative techniques to quantify matrix changes at early stages will be increasingly important in the future to tailor therapies and better understand disease progression on a molecular level.
NOVEL MEDIATORS OF CHONDROCYTE GENE EXPRESSION IN DEVELOPMENT AND OSTEOARTHRITIS
Mary B. Goldring
The human adult articular chondrocyte is a unique cell type that has reached a terminally differentiated state within the cartilage matrix as an end-point of development. In cartilage of patients with osteoarthritis (OA), the chondrocytes may undergo phenotypic modulation in response to alterations in the environment due to the mechanical loading and inflammation. Isolated chondrocytes in primary culture have provided useful models to study cellular responses to alterations in the environment such as those occurring in different forms of arthritis [1] . Immortalized chondrocytes of human origin have been developed to serve as reproducible models for studying transcriptional regulation of chondrocyte function by inflammatory mediators such as interleukin-1β (IL-1β) [2] . We reported previously that activation of EGR-1 by IL-1β results in early, transient suppression of proximal COL2A1 promoter activity by displacement of Sp1 from GC boxes [3] . The epithelium-specific ETS (ESE)-1 is expressed predominantly in epithelial cells but can also be induced in other cell types including chondrocytes in response to inflammatory mediators such as IL-1β and upregulates IL-1-induced genes, including COX-2 [4, 5] . ESE-1 is a potent transcriptional suppressor of COL2A1 promoter activity in chondrocytes, accounting for the sustained, NF-κB-dependent inhibition by IL-1β, and acts by interfering with the activator functions of CBP/300 and Sox9 [6] . Our finding that ESE-1 protein is localized intracellularly in chondrocytes in cartilage from patients with osteoarthritis but not from individuals with normal joints and that IL-1β induces ESE-1 expression in adult human articular chondrocytes further suggest a fundamental role for ESE-1 in cartilage degeneration and suppression of repair. Recently, we have identified novel pathways that regulate chondrocyte terminal differentiation in the growth plate during endochondral ossification and also modulate chondrocyte phenotype in osteoarthritis. A microarray study of BMP-2-induced genes resulted in the discovery of a novel role for growth arrest and DNA damage inducible (GADD) 45β in chondrocyte survival and up-regulation of MMP-13 and Col10a1 gene expression during chondrogenesis [7, 8] . The GADD45β gene product is implicated in the stress response, cell cycle arrest and apoptosis. GADD45α and γ, which are important mediators of tumor cell apoptosis, are not upregulated by BMP-2. In recent studies, we have begun to investigate the relative contributions of ESE-1 and GADD45β to OA initiation and progression, since both factors up-regulate MMP-13 gene expression and are expressed in early OA cartilage and at 3 to 6 months in the cho/+ mouse model, which develops OA-like pathology due to mutations that disrupt the collagen network [9] . We have also asked whether similar mechanisms regulate chondrocyte hypertrophy both during remodeling of the calcified cartilage matrix of the hypertrophic zone of the growth plate and during tidemark advancement in OA.
Both processes share the features of chondrocyte hypertrophy, apoptosis and MMP-13-mediated remodeling. The distribution of immunostaining for GADD45β in early OA cartilage at sites peripheral to the lesion in chondrocyte clusters and in deep zone chondrocytes, along with our finding that it suppresses apoptosis, suggests that GADD45β may serve as a survival factor in activated chondrocytes, while promoting hypertrophy during tidemark advancement. An understanding of the relative contributions of the GADD45β and ESE-1 pathways to physiological cartilage homeostasis will provide understanding of the molecular mechanisms responsible for dysregulated cartilage remodeling in joint disease.
